| Aug'19 | Aug'18 | Aug'17 | Aug'16 | Aug'15 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income (loss) | ||||||
51,332 | 119,463 | -7,795 | -19,960 | -46,451 | ||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||
Depreciation and amortization | ||||||
29,206 | 26,182 | 33,238 | 31,480 | 50,145 | ||
Share-based compensation | ||||||
18,199 | 10,558 | 5,364 | 3,872 | 6,132 | ||
Provision for doubtful accounts receivable | ||||||
-90 | -86 | -51 | 18 | 109 | ||
Deferred income tax benefit | ||||||
-719 | -2,820 | -2,389 | -1,417 | -2,464 | ||
Gain on disposal of property and equipment | ||||||
-77 | -691 | -352 | 55 | -122 | ||
Loss on extinguishment of debt | ||||||
- | - | -16,580 | - | - | ||
Loss on early repayment of debt | ||||||
- | - | 6,744 | - | - | ||
Amortization of debt discounts and issuance costs | ||||||
2,803 | 2,972 | 8,231 | 4,696 | 4,562 | ||
Write-off of other assets | ||||||
- | 250 | - | - | 1,582 | ||
Change in fair value of contingent consideration | ||||||
-2,700 | -3,000 | - | - | - | ||
Write-off of deferred initial public offering costs | ||||||
- | - | - | - | 3,962 | ||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
-35,240 | 55,297 | 40,426 | -44,922 | -8,597 | ||
Inventories | ||||||
-102,083 | 42,435 | 21,851 | -31,326 | 19,989 | ||
Prepaid expenses and other assets | ||||||
1,606 | 8,736 | 58 | -11,007 | 451 | ||
Accounts payable | ||||||
-64,569 | 17,548 | -10,608 | -86,588 | 53,236 | ||
Accrued expenses and other liabilities | ||||||
401 | 2,617 | 11,736 | -4,251 | -18,330 | ||
Net cash provided by operating activities | ||||||
169,657 | 67,907 | -933 | 15,050 | 40,762 | ||
Capital expenditures and deposits on equipment | ||||||
33,433 | 25,738 | 18,678 | 13,844 | 31,663 | ||
Restricted cash | ||||||
- | - | - | -194 | 6,115 | ||
Proceeds from sale of property and equipment | ||||||
81 | 305 | 651 | 281 | 161 | ||
Acquisition of business, net of cash acquired | ||||||
76,088 | 42,316 | - | - | - | ||
Net cash used in investing activities | ||||||
-109,440 | -67,749 | -18,027 | -13,369 | -8,716 | ||
Cash flows from financing activities: | ||||||
Long-term debt payments | ||||||
6,753 | 24,269 | 19,698 | 16,694 | 13,258 | ||
Issuance of ordinary shares from IPO, net of underwriting commissions | ||||||
- | - | 63,507 | - | - | ||
Payment of costs related to IPO | ||||||
- | 1,591 | 1,149 | - | 3,094 | ||
Fees paid for revolving line of credit financing | ||||||
- | 768 | 3,167 | - | - | ||
Purchase of other assets | ||||||
- | - | - | - | 1,597 | ||
Proceeds from Escrow Release related to sale of business | ||||||
- | - | - | - | 30,498 | ||
Proceeds from issuance of long-term debt, net of costs paid | ||||||
- | 59,365 | 156,962 | 5,771 | 14,060 | ||
Payment for extinguishment of long-term debt | ||||||
- | - | 151,946 | - | - | ||
Proceeds from borrowings under revolving line of credit | ||||||
254,500 | 429,395 | 457,750 | 279,200 | 357,000 | ||
Repayments of borrowings under revolving line of credit | ||||||
254,500 | 461,684 | 457,750 | 279,200 | 357,000 | ||
Proceeds from issuance of ordinary shares from share option exercises | ||||||
5,070 | 7,496 | 406 | 133 | 12 | ||
Tax payments due upon issuance of ordinary shares for release of RSUs | ||||||
520 | - | 763 | - | - | ||
Proceeds from issuance of ordinary shares from ESPP | ||||||
2,303 | - | - | - | - | ||
Distribution of share premium | ||||||
- | - | - | - | 28,338 | ||
Payment for Storage options related to Escrow Release | ||||||
- | - | - | - | 1,127 | ||
Payment for strike price reductions | ||||||
- | - | - | - | 900 | ||
Early debt payment for long-term debt | ||||||
- | - | 61,127 | - | - | ||
Repurchase of ordinary shares | ||||||
- | - | - | 124 | - | ||
Net cash provided by financing activities | ||||||
100 | 7,944 | -16,975 | -10,914 | -32,645 | ||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
588 | -331 | -28 | -227 | -9,399 | ||
Net increase in cash, cash equivalents and restricted cash | ||||||
60,905 | 7,771 | -35,963 | -9,460 | -9,998 | ||
Supplemental disclosures of cash flow information: | ||||||
Cash paid during the period: | ||||||
Cash paid for interest | ||||||
20,648 | 15,291 | 21,458 | 22,413 | 23,750 | ||
Cash paid for income taxes, net of refunds | ||||||
15,306 | 21,832 | 8,095 | 5,300 | 7,996 | ||
Noncash activities information: | ||||||
Capital expenditures included in accounts payable at period end | ||||||
1,437 | 724 | 153 | 552 | 633 | ||
Fair value of ordinary shares issued and holdback in connection with acquisition | ||||||
10,785 | - | - | - | - | ||
Acquisition consideration held back to satisfy potential indemnification claims | ||||||
1,676 | 3,479 | - | - | - | ||
Fair value of contingent consideration for acquisition of business | ||||||
2,700 | 3,000 | - | - | - | ||
Fair value of warrants issued | ||||||
- | - | 21,341 | - | - | ||
IPO costs included in accounts payable and accrued liabilities at period end | ||||||
- | - | 1,591 | - | - | ||
Unpaid debt fees related to term loan and revolver | ||||||
- | 178 | 768 | - | - | ||